{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:43:09Z","timestamp":1792723389129,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.lanepe.2021.100129","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T07:01:58Z","timestamp":1623049318000},"page":"100129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Paediatric outpatient prescriptions in France between 2010 and 2019: A nationwide population-based study"],"prefix":"10.1016","volume":"7","author":[{"given":"Marion","family":"Taine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Offredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Dray-Spira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Weill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Zureik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2021.100129_bib0001","unstructured":"European Medicines Agency. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use: e11 clinical investigation of medicinal products in the Paediatric population. 2001. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e11r1-guideline-clinical-investigation-medicinal-products-pediatric-population-revision-1_en.pdf. Access July 6,2020."},{"issue":"12","key":"10.1016\/j.lanepe.2021.100129_bib0002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"issue":"3 Pt 2","key":"10.1016\/j.lanepe.2021.100129_bib0003","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1542\/peds.104.S3.593","article-title":"Is pediatric labeling really necessary?","volume":"104","author":"Christensen","year":"1999","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.lanepe.2021.100129_bib0004","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00228-009-0679-7","article-title":"Drug prescriptions to outpatient children: a review of the literature","volume":"65","author":"Clavenna","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.lanepe.2021.100129_bib0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00431-005-1698-8","article-title":"A literature review on off-label drug use in children","volume":"164","author":"Pandolfini","year":"2005","journal-title":"Eur J Pediatr"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100129_bib0006","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/clpt.2012.26","article-title":"Off-label drug use in pediatric patients","volume":"91","author":"Kimland","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100129_bib0007","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1542\/peds.2014-0764","article-title":"Off-label prescribing in pediatric outpatients","volume":"135","author":"Palmaro","year":"2015","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.lanepe.2021.100129_bib0008","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/adc.2006.105692","article-title":"The EU's new paediatric medicines legislation: serving children's needs?","volume":"92","author":"Permanand","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.lanepe.2021.100129_bib0009","unstructured":"European parliament resolution of 15 December 2016 on the regulation on paediatric medicines (2016\/2902(RSP)). http:\/\/www.europarl.europa.eu\/doceo\/document\/TA-8-2016-0511_EN.pdf. Access July 1, 2020."},{"key":"10.1016\/j.lanepe.2021.100129_bib0010","unstructured":"World Health Organization. Introduction to drug utilization research. 2003. https:\/\/apps.who.int\/medicinedocs\/en\/d\/Js4876e\/. Access July 1, 2020."},{"issue":"12","key":"10.1016\/j.lanepe.2021.100129_bib0011","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/j.1651-2227.2005.tb01854.x","article-title":"Prescribers' indications for drugs in childhood: a survey of five European countries (Spain, France, Bulgaria, Slovakia and Russia)","volume":"94","author":"Sanz","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.lanepe.2021.100129_bib0012","doi-asserted-by":"crossref","first-page":"a2245","DOI":"10.1136\/bmj.a2245","article-title":"Drug use in children: cohort study in three European countries","volume":"337","author":"Sturkenboom","year":"2008","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.lanepe.2021.100129_bib0013","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.2018.5690","article-title":"Trends in prescription medication use among children and adolescents-United States, 1999-2014","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100129_bib0014","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40272-018-0303-3","article-title":"Trends in outpatient prescription medicine use in New Zealand children 2010-2015: a national population-based study","volume":"20","author":"Tomlin","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"10","key":"10.1016\/j.lanepe.2021.100129_bib0015","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/archdischild-2014-307224","article-title":"Drug use in French children: a population-based study","volume":"100","author":"Benard-Laribiere","year":"2015","journal-title":"Arch Dis Child"},{"issue":"23","key":"10.1016\/j.lanepe.2021.100129_bib0016","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1001\/jama.2017.18715","article-title":"Association of broad- vs narrow-spectrum antibiotics with treatment failure, adverse events, and quality of life in children with acute respiratory tract infections","volume":"318","author":"Gerber","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100129_bib0017","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Schacke","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.lanepe.2021.100129_bib0018","article-title":"Nasal decongestants in monotherapy for the common cold","volume":"10","author":"Deckx","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100129_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2016-000137","article-title":"Comprehensive evidence-based review on European antitussives","volume":"3","author":"Morice","year":"2016","journal-title":"BMJ Open Respir Res"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100129_bib0020","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MPG.0000000000000657","article-title":"Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide","volume":"60","author":"Mt-Isa","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.lanepe.2021.100129_bib0021","unstructured":"General Commission for Strategy and Foresight. Les m\u00e9dicaments et leurs usages: comment favoriser une consommation adapt\u00e9e ? 2014. https:\/\/www.strategie.gouv.fr\/sites\/strategie.gouv.fr\/files\/atoms\/files\/2014-03-04-Medicaments-Usages2.pdf Access January 1, 2021."},{"issue":"3","key":"10.1016\/j.lanepe.2021.100129_bib0022","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/eurpub\/ckm118","article-title":"Prescribing patterns for upper respiratory tract infections in general practice in France and in the Netherlands","volume":"18","author":"Rosman","year":"2008","journal-title":"Eur J Public Health"},{"issue":"167","key":"10.1016\/j.lanepe.2021.100129_bib0023","article-title":"Le d\u00e9remboursement des m\u00e9dicaments en France entre 2002 et 2011: \u00e9l\u00e9ments d\u2019\u00e9valuation","author":"Pichetti","year":"2011","journal-title":"Questions d\u2019\u00e9conomie de la sant\u00e9"},{"key":"10.1016\/j.lanepe.2021.100129_bib0024","series-title":"Communiqu\u00e9 de presse: contre-indication chez l'enfant de moins de 2 ans des m\u00e9dicaments antitussifs antihistaminiques H1 de 1\u00e8re g\u00e9n\u00e9ration et du fenspiride utilis\u00e9s dans le traitement de la toux","year":"2011"},{"issue":"12","key":"10.1016\/j.lanepe.2021.100129_bib0025","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s40265-017-0751-z","article-title":"Working towards an appropriate use of ibuprofen in children: an evidence-based Appraisal","volume":"77","author":"de Martino","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.lanepe.2021.100129_bib0026","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jpeds.2019.09.017","article-title":"Association between national treatment guidelines for upper respiratory tract infections and outpatient pediatric antibiotic use in france: an interrupted time-series analysis","volume":"216","author":"Trinh","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.lanepe.2021.100129_bib0027","doi-asserted-by":"crossref","first-page":"k3532","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.lanepe.2021.100129_bib0028","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100129_bib0029","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00228-019-02810-1","article-title":"Use of proton pump inhibitors in adults in France: a nationwide drug utilization study","volume":"76","author":"Lassalle","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.lanepe.2021.100129_bib0030","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/pds.4898","article-title":"Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury","volume":"28","author":"Coste","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.lanepe.2021.100129_bib0031","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC (Anatomical Therapeutic Chemical Classification)\/DDD Index 2020. https:\/\/www.whocc.no\/atc_ddd_index\/."},{"issue":"5","key":"10.1016\/j.lanepe.2021.100129_bib0032","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ije\/dys142","article-title":"Incidence rates in dynamic populations","volume":"41","author":"Vandenbroucke","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.lanepe.2021.100129_bib0033","unstructured":"Institut National des Statistiques et des Etudes Economiques. Population totale par sexe et \u00e2ge au 1er janvier 2020, France. Bilan d\u00e9mographique 2019.https:\/\/www.insee.fr\/fr\/statistiques\/1912926."},{"issue":"426","key":"10.1016\/j.lanepe.2021.100129_bib0034","first-page":"880","article-title":"Everyday symptoms in childhood: occurrence and general practitioner consultation rates","volume":"48","author":"Bruijnzeels","year":"1998","journal-title":"Br J Gen Pract"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100129_bib0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/fampra\/cmi035","article-title":"The prevalence of symptoms and consultations in pre-school children in the Avon Longitudinal Study of Parents and Children (ALSPAC): a prospective cohort study","volume":"22","author":"Hay","year":"2005","journal-title":"Fam Pract"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100129_bib0036","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11882-011-0227-2","article-title":"Medication adherence in the asthmatic child and adolescent","volume":"11","author":"Desai","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100129_bib0037","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.mop.0000245357.68207.9b","article-title":"Medical adherence and childhood chronic illness: family daily management skills and emotional climate as emerging contributors","volume":"18","author":"Fiese","year":"2006","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100129_bib0038","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00228-012-1343-1","article-title":"Prescription drug dispensing profiles for one million children: a population-based analysis","volume":"69","author":"Zhang","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.lanepe.2021.100129_bib0039","unstructured":"The Danish Health Data Authority. Statistics on the total sales of medicines in Denmark 1996-2019. https:\/\/www.medstat.dk\/en.Access July 1, 2020."},{"key":"10.1016\/j.lanepe.2021.100129_bib0040","article-title":"L'uso dei farmaci in Italia","year":"2018","journal-title":"Rapporto OsMed"},{"issue":"10100","key":"10.1016\/j.lanepe.2021.100129_bib0041","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Disease","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lanepe.2021.100129_bib0042","unstructured":"The Commonwealth Fund. International health care system profiles. https:\/\/www.commonwealthfund.org\/international-health-policy-center\/countries. Access January 1, 2021."},{"issue":"4 Pt 1","key":"10.1016\/j.lanepe.2021.100129_bib0043","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1542\/peds.103.4.711","article-title":"The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior","volume":"103","author":"Mangione-Smith","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100129_bib0044","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hpm.816","article-title":"An overview of pharmaceutical policy in four countries: france, Germany, the Netherlands and the United Kingdom","volume":"20","author":"Mossialos","year":"2005","journal-title":"Int J Health Plann Manage"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100129_bib0045","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00228-018-2416-6","article-title":"Efficacy of phloroglucinol for treatment of abdominal pain: a systematic review of literature and meta-analysis of randomised controlled trials versus placebo","volume":"74","author":"Blanchard","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.lanepe.2021.100129_bib0046","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Commission de Transparence sur la metopimazine. Avis du 4 avril 2018. https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-15607_VOGALENE_PIC_RI_Avis2_CT15607.pdf. Access July 1, 2020."},{"issue":"6","key":"10.1016\/j.lanepe.2021.100129_bib0047","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11882-016-0620-y","article-title":"Adverse effects of nonsystemic steroids (Inhaled, Intranasal, and Cutaneous): a review of the literature and suggested monitoring tool","volume":"16","author":"Gupta","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"10.1016\/j.lanepe.2021.100129_bib0048","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.mayocp.2013.04.021","article-title":"Age and sex patterns of drug prescribing in a defined American population","volume":"88","author":"Zhong","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.lanepe.2021.100129_bib0049","unstructured":"The Norwegian Institute of Public Health (NIPH). Norwegian prescription database. create a report. http:\/\/www.norpd.no. Access July 1, 2020."},{"issue":"3","key":"10.1016\/j.lanepe.2021.100129_bib0050","first-page":"175","article-title":"Key potentially inappropriate drugs in pediatrics: the KIDs list","volume":"25","author":"Meyers","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100129_bib0051","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1398-9995.2008.01884.x","article-title":"Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the international study of asthma and allergies in childhood (ISAAC) phase three","volume":"64","author":"Ait-Khaled","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.lanepe.2021.100129_bib0052","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijporl.2017.11.007","article-title":"Iatrogenic Cushing's syndrome and adrenal insufficiency in infants on intranasal dexamethasone drops for nasal obstruction - Case series and literature review","volume":"105","author":"Joshi","year":"2018","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"9","key":"10.1016\/j.lanepe.2021.100129_bib0053","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.arcped.2009.06.009","article-title":"Prevalence of asthma among children in France","volume":"16","author":"Delmas","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.lanepe.2021.100129_bib0054","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention, 2019. www.ginasthma.org Access January 1, 2021."},{"key":"10.1016\/j.lanepe.2021.100129_bib0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/JAA.S233268","article-title":"Treatment adherence in adolescents with asthma","volume":"13","author":"Kaplan","year":"2020","journal-title":"J Asthma Allergy"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100129_bib0056","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bcpt.13191","article-title":"Use of proton pump inhibitors among Danish children: a 16-year register-based nationwide study","volume":"124","author":"Aznar-Lou","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100129_bib0057","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4292\/wjgpt.v7.i4.531","article-title":"Widespread use of gastric acid inhibitors in infants: are they needed? Are they safe?","volume":"7","author":"Safe","year":"2016","journal-title":"World J Gastrointest Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100129_bib0058","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1715","article-title":"Implementation of a guideline to decrease use of acid-suppressing medications in the NICU","volume":"140","author":"Angelidou","year":"2017","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.lanepe.2021.100129_bib0059","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.arcped.2014.04.030","article-title":"Let's stop proton pump inhibitor prescriptions for suspected GERD in non-validated indications!","volume":"21","author":"Mouterde","year":"2014","journal-title":"Arch Pediatr"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100129_bib0060","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MPG.0000000000001889","article-title":"Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for pediatric gastroenterology, hepatology, and nutrition and the european society for pediatric gastroenterology, hepatology, and nutrition","volume":"66","author":"Rosen","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"8","key":"10.1016\/j.lanepe.2021.100129_bib0061","first-page":"2344","article-title":"Community antibiotic prescribing for children in France from 2015 to 2017: a cross-sectional national study","volume":"75","author":"Trinh","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100129_bib0062","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1542\/peds.2008-1862","article-title":"Prevention of rickets and vitamin D deficiency in infants, children, and adolescents","volume":"122","author":"Wagner","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.lanepe.2021.100129_bib0063","doi-asserted-by":"crossref","DOI":"10.13162\/hro-ors.v7i2.3578","article-title":"Innovation in physician remuneration in France. What lessons for Canada?","author":"Pomey","year":"2019","journal-title":"Health Reform Observer"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100129_bib0064","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MLR.0b013e318245a160","article-title":"Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review","volume":"50","author":"Dusetzina","year":"2012","journal-title":"Med Care"},{"issue":"15","key":"10.1016\/j.lanepe.2021.100129_bib0065","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don't physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100129_bib0066","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1542\/peds.2004-1133","article-title":"How do you improve compliance?","volume":"115","author":"Winnick","year":"2005","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100129_bib0067","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jaip.2014.01.006","article-title":"Are you comfortable with over-the-counter intranasal steroids for children? A call to action","volume":"2","author":"Rachelefsky","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.lanepe.2021.100129_bib0068","unstructured":"Zorginstituut Nederland. GIPdatabank 2019. https:\/\/gipdatabank.nl\/.Access March 22, 2021."}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622100106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622100106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:46:26Z","timestamp":1763009186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266677622100106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":68,"alternative-id":["S266677622100106X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2021.100129","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paediatric outpatient prescriptions in France between 2010 and 2019: A nationwide population-based study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2021.100129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100129"}}